Statistics from Altmetric.com
Those of us who were on the front line during the 2009 H1N1 swine flu pandemic will remember giving antiviral neuraminidase inhibitors to, it seemed, almost every febrile child—particularly oseltamivir (Tamiflu), as guided by official advice. My impression at the time was that it didn't help much, and vomiting was common.
A controversy has raged in the media (www.bbc.co.uk/news/health-26954482), and has become a ‘cause célèbre’ for those who want pharmaceutical companies to make public all their trial data, not just those that favour the drug. The BMJ has been active in this campaign, and has now published …